CIK 0001595248
- Non-accelerated filer
- Smaller reporting company
Genprex, Inc.
Sign in to watch- Ticker
- GNPX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- Operating
- EIN
- 900772347
- Phone
- +1 512-537-7997
- Business address
- 3300 BEE CAVE ROAD SUITE 650-227, AUSTIN, TX, 78746
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Confer Ryan M. President, CEO and CFO | Shares withheld for taxes | −9,330 | $2.00 | $19K | 36,331 |
| 2025-12-22 | Confer Ryan M. President, CEO and CFO | Grant or award | +45,000 | 45,661 | ||
| 2025-06-30 | Confer Ryan M. President, CEO and CFO | Shares withheld for taxes | −5,775 | $0.23 | $1K | 32,968 |
| 2025-02-18 | Confer Ryan M. President, CEO and CFO | Shares withheld for taxes | −395 | $0.41 | $162 | 38,743 |
| 2024-12-05 | Confer Ryan M. President, CEO and CFO | Grant or award | +29,375 | 39,138 | ||
| 2024-02-18 | Confer Ryan M. Chief Financial Officer | Shares withheld for taxes | −1,126 | $4.40 | $5K | 9,763 |
| 2023-02-18 | Confer Ryan M. Chief Financial Officer | Grant or award | +245,000 | 435,499 | ||
| 2022-07-28 | Confer Ryan M. Chief Financial Officer | Exercise or conversion | +116,973 | $0.02 | $2K | 190,499 |
| 2022-07-28 | Confer Ryan M. Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −116,973 | 0 | ||
| 2022-02-04 | Confer Ryan M. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +341,750 | 341,750 | ||
| 2021-03-19 | Confer Ryan M. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +235,000 | 235,000 | ||
| 2020-08-21 | Confer Ryan M. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +270,000 | 270,000 | ||
| 2019-01-25 | Confer Ryan M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +230,769 | 230,769 | ||
| 2018-05-23 | Confer Ryan M. Chief Financial Officer | Grant or award · Stock option (right to buy) | +327,236 | 327,236 |
Page 1 of 1 · 14 trades